Skip to main content
. 2023 Feb 25;16(3):356. doi: 10.3390/ph16030356

Figure 1.

Figure 1

Selected HDACi, including the established HDAC pharmacophore model. Cap, linker, and ZBG are highlighted in black, blue, and red, respectively. (A) Structures of FDA-approved HDACi. (B) Structures of the peptoid-based HDACi DDK-137 (I) and VK1 (II) [7,8].